Delivery Order SPE2DB24D1205-SPE2DB25FCVMX
Award Date
4/3/25
Potential Completion Date
4/24/25
Potential Value
$6.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,943.08 firm fixed-price delivery order is for the supply of VYEPTI 100 MG/ML VIALML, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,157.18 firm fixed-price delivery order is for VYEPTI 100 MG/ML VIALML, with a period of performance through April 16, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,313.20 firm fixed-price delivery order is for the supply of VYEPTI 100 MG/ML VIAL medication. The contract has an ultimate completion date of December 13, 2024. This award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award, with ID SPE2DB24D1205|SPE2DB25FCWPH, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VYEPTI 100 MG/ML vials, a pharmaceutical product, with a ceiling value of $6,943.08. The contract is a Firm Fixed Price Delivery Order, with a performance period ending on May 29, 2025. The award date is May 7, 2025, and there is no set-aside designation, indicating open...
This federal contract award, identified as SPE2DB24D1205|SPE2DB25FCSVQ, was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,471.54, is for the delivery of the medication VYEPTI 100 MG/ML VIALML. This is a firm-fixed-price delivery order contract, with an ultimate completion date of January 29, 2025. The contract does not have a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of pharmaceutical products, including VYEPTI 100 MG/ML vials. The $4,270.04 firm fixed price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,287.20 firm fixed-price contract is for the supply of VYEPTI 100 MG/ML VIALML, a medication, with a performance period ending on February 21, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,270.04 firm fixed-price contract is for the supply of VYEPTI 100 MG/ML VIALML, a pharmaceutical product. This contract does not have a set-aside designation. The award is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, which enables the...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $3,141.00 issued under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract provides for the delivery of VYEPTI 100 MG/ML VIALML, a medical product, with a period of performance through October 11, 2023. This IDC, valued at $999,999,999, serves as a primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $8,540.08 firm fixed price delivery order is for the supply of VYEPTI 100 MG/ML VIALML, a specialty pharmaceutical product. This award is associated with a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December...